Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


THE UNIVERSITY OF MANITOBA

THE UNIVERSITY OF MANITOBA Patent applications
Patent application numberTitlePublished
20110050214SYSTEM AND METHOD FOR MEASURING MAGNETIC FIELD STRENGTH USING A MECHANICAL RESONATOR - Methods and apparatus for measuring magnetic field are provided. A resonator having a resonant frequency is that varies as a function of magnetic field is driven with a drive signal, and produces an output that is converted to electrical form. This output is then processed to isolate interference components due to the drive signal and to produce a sense signal. The sense signal is the processed to produce the drive signal. The sense signal is also processed to produce an output representative of the magnetic field.03-03-2011
20090027611Metal Nanoparticle and Use Thereof for Inducing Chirality in Liquid Crystal Phases - The invention provides a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal. The monolayer-protected metal nanoparticle may be used as a chiral dopant in a liquid crystal. Accordingly, the invention also provides a colloidal suspension or dispersion comprising a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal, and a liquid crystal.01-29-2009
20090018343Fluorous Oxazolidinone Chiral Auxiliary Compounds and Methods of Manufacture - The present invention relates generally to perfluoroalkyl chiral auxiliary compounds and methods of manufacture. These compounds have the functionality to effectively support the synthesis of chiral compounds in single reactions, high-throughput parallel reactions, or combinatorial reactions The invention relates to two oxazolidinone chiral auxiliaries (1) and (2): wherein R01-15-2009
20080318880Neoadjuvant treatment of Breast Cancer - Neoadjuvant treatment of inflammatory or T3 to T4 breast cancer is carried out by administering to such patients a number of cycles of chemotherapy treatment in which DPPE first is administered followed by a combination of anthracyclines and taxanes.12-25-2008
20080226653Inhibition of Platelet Aggregation - The present invention relates generally to the field of hyperglycemia-induced complications. More particularly, it concerns methods and compositions for the treatment and prevention of microvascular complications associated with diabetes. In one embodiment, the present invention provides a method of inhibiting hyperglycemia-induced platelet activation in a subject by administering to the subject an effective amount of a TRPC6 inhibitor.09-18-2008

Patent applications by THE UNIVERSITY OF MANITOBA